OasisLMS

This 3-part webinar series will provide community-based healthcare providers with education on diagnosing, treating, and providing effective multidisciplinary management of patients with known or suspected cardiac amyloidosis. Registration gives learners access to all three webinars and recordings. 

Each webinar will be 2 hours with short didactic and case-based discussion and offers up to 2 CME credits.

To claim your CME certificate for any one of the three webinar activities, you must first complete its post-test and evaluation. To do this, click the “Get Started” or “Login” button. Please note, the button you see is dependent if you are currently logged in. Upon clicking this button, follow the cues to move through the post-test and evaluation to receive your certificate.

The program is intended for nuclear cardiologists, multimodality imaging cardiologists, general cardiologists, hematologists, neurologists,and  primary care providers.

This series of webinars is designed to enhance the ability of community-based healthcare providers to diagnose, treat and manage patients with cardiac amyloidosis. Early diagnosis and treatment are important to improve patient outcomes.

At the conclusion of the three webinars, learners should be able to: 

• Describe signs and symptoms of ATTR-CM, diagnostic work-up of amyloidosis
• Explain the importance of testing to rule out light chain amyloidosis
• Identify high risk scenarios for suspected ATTR-CM
• Prescribe disease-modifying therapy earlier to improve patient outcomes
• Understand the current armamentarium of drug treatment
• Learn how treatment can impact patients in your practice
• Evaluate potential approaches to disease monitoring
• Identify unanswered questions about treating ATTR-CM
• Recognize polyneuropathy in diagnosing patients
• Discuss the importance of genetic testing in effective patient management
• Develop strategies for appropriate patient management and multidisciplinary needs within a center of excellence

Many community-based physicians and other healthcare professionals lack the ability to appropriately diagnose and treat amyloidosis and need guidance on establishing a center to adequately manage patients. These webinars will enhance the ability of community-based healthcare providers to diagnose, treat and manage patients with cardiac amyloidosis. Early diagnosis and treatment are important to improve patient outcomes.

Evaluation Deadline: AMA PRA Category 1 Credits™- December 31, 2026. The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Physicians: The American Society of Nuclear Cardiology designates these hybrid internet live and recorded webinars for a maximum of 2 AMA PRA Category 1 Credits^TM each. Physicians should only claim credit commensurate with the extent of their participation in the activity.

As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.  In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through the disclosure of all financial relationships with ineligible companies and mitigation of conflicts of interest.  The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy.  All persons who influenced the content of this activity are required to disclose all financial relationships.  The American Society of Nuclear Cardiology has reviewed these disclosures and mitigated or managed all identified conflicts of interest through a peer review process.

Part 1 Release Date: June 9, 2026
Part 2 Release Date: June 17, 2026
Part 3 Release Date: June 25, 2026
Expiration Date: December 31, 2026
After December 31, 2026, a fee will be charged to obtain your certificate(s).

This activity is comprised of a series of webinars that will/did take place on June 9, 2026, June 17, 2026, and June 25, 2026. Online content available to learners includes the recorded lecture.  A Post-Test and Evaluation must be completed in order to claim credit for this each activity in the series.

This activity is supported by an unrestricted educational grant from BridgeBio.

American Society of Nuclear Cardiology 
10300 Eaton Place, Suite 301
Fairfax, VA  22030 
703-459-2555 | info@asnc.org | www.ASNC.org